Aequim Alternative Investments LP Becton Dickinson & CO Transaction History

Aequim Alternative Investments LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$229.71 - $259.35 $7.47 Million - $8.43 Million	-32,500 Reduced 71.59%	12,900 $3.19 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $663,390 - $3.43 Million	13,000 Added 40.12%	45,400 $10.1 Million
Q2 2022 Aug 15, 2022	SELL	$234.74 - $275.42 $11.8 Million - $13.9 Million	-50,450 Reduced 60.89%	32,400 $7.99 Million
Q1 2022 May 10, 2022	BUY	$243.64 - $270.48 $9.73 Million - $10.8 Million	39,950 Added 93.12%	82,850 $22 Million
Q4 2021 Feb 09, 2022	BUY	$230.08 - $250.94 $2.09 Million - $2.28 Million	9,100 Added 26.92%	42,900 $10.8 Million
Q3 2021 Nov 04, 2021	BUY	$232.72 - $256.47 $6.12 Million - $6.75 Million	26,300 Added 350.67%	33,800 $8.31 Million
Q1 2021 May 12, 2021	BUY	$232.09 - $256.88 $1.74 Million - $1.93 Million	7,500 New	7,500 $1.82 Million

1,737

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Aequim Alternative Investments LP, based on Form 13F filings with the SEC.

Stay updated on Aequim Alternative Investments LP with notifications on news.